Suggested Topics within your search.
Suggested Topics within your search.
- Cancer 1
- Immune System 1
- Immunity 1
- Orthopedic surgery 1
- Orthopedics 1
- Pediatrics 1
- Tumors 1
-
2681
An Unusual Case of Primary Aneurysmal Bone Cyst of the Patella with a Review of Literature
Published 2024-01-01Subjects: Get full text
Article -
2682
Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment
Published 2025-01-01Subjects: Get full text
Article -
2683
An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers
Published 2025-02-01Subjects: Get full text
Article -
2684
Clinical characteristics and treatment outcomes of patients with insulinoma–a single center's experience of 76 cases over a 10-year period
Published 2025-01-01Subjects: Get full text
Article -
2685
Bilateral inverted papilloma: Case report and literature review
Published 2025-03-01Subjects: Get full text
Article -
2686
A Rare Case of Testicular Tuberculosis Mimicking as Testicular Malignancy
Published 2025-01-01Subjects: Get full text
Article -
2687
Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-α1 in advanced metastatic solid tumors: a multicenter Phase II clinical trial
Published 2025-02-01“…HFRT was administered to targeted tumors, and GM-CSF was administered for 14 days from day 1 of radiotherapy. …”
Get full text
Article -
2688
Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib/II trial
Published 2025-02-01“…Abstract Purpose Open-label phase Ib/II study to investigate the safety and efficacy of LBL-007, an anti-LAG-3 antibody, plus toripalimab, an anti-PD-1 antibody, in patients with previously treated advanced nasopharyngeal carcinoma (NPC) and other solid tumors. Methods Patients with advanced tumors refractory to prior standard therapies were enrolled. …”
Get full text
Article -
2689
-
2690
-
2691
-
2692
Intermittent fasting boosts antitumor immunity by restricting CD11b+Ly6Clow Ly6Glow cell viability through glucose metabolism in murine breast tumor model
Published 2024-07-01“…Herein we observed that two cycles of fasting treatment significantly inhibited breast tumor growth and lung tissue metastasis, as well as prolonged overall survival in mice bearing 4T1 and 4T07 breast cancer. …”
Get full text
Article -
2693
Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes
Published 2021-09-01“…In addition, conditional knockout mice for Nrf2 and p62 were used to detect these markers, together with the monitoring of in vivo tumor growth. RNA sequencing was performed for CD8TILs and tumor cells. …”
Get full text
Article -
2694
-
2695
-
2696
Research status of care experience and needs of family caregivers on gastrointestinal cancer patients (消化道肿瘤患者家庭照护者照护体验及需求研究现状)
Published 2023-01-01Subjects: “…gastrointestinal tumors…”
Get full text
Article -
2697
Application of green nursing technology for tumors in a lung cancer patient with COVID-19 (1例肺癌合并新型冠状病毒感染患者的肿瘤绿色调护体会)
Published 2023-11-01Subjects: “…green nursing technology for tumors…”
Get full text
Article -
2698
Tumor-derived exosomal lncRNA-MIR193BHG promotes bone metastasis of breast cancer by targeting the miR-489-3p/DNMT3A signaling axis in osteoclasts
Published 2025-01-01“…Exosomes, small vesicles capable of mediating intercellular communication, play a crucial role in tumor metastasis. Results This study investigated the role of tumor-derived exosomal long noncoding RNA (lncRNA)-MIR193BHG in breast cancer bone metastasis. …”
Get full text
Article -
2699
MMP9-Associated Tumor Stem Cells, CCL1-Silenced Dendritic Cells, and Cytokine-Induced Killer Cells Have a Remarkable Therapeutic Efficacy for Acute Myeloid Leukemia by Activating T Cells
Published 2023-01-01“…Dendritic cells (DC) are specialized antigen-presenting cells, and cytokine-induced killer (CIK) cells have a specific killing activity to a variety of tumors. However, the underlining mechanism and function of DC-CIK cells in acute myeloid leukemia (AML) remain largely elusive. …”
Get full text
Article -
2700
Comparison between 18F-DCFPyL PET/MRI-guided ultrasound fusion targeted biopsy and systematic biopsy for tumor detection and grading in selected patients: A prospective randomized controlled trial
Published 2025-01-01“…The TB group successfully identified all tumors, whereas five patients in the control group initially missed diagnosis. …”
Get full text
Article